Deal expands pharmaceutical company’s portfolio of cancer drugs
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
https://www.wsj.com/health/pharma/bristol-myers-squibb-to-acquire-mirati-therapeutics-in-deal-worth-up-to-5-8-billion-7d83106BRIAN SNYDER/REUTERS Bristol Myers Squibb will acquire Mirati Therapeutics in a transaction that values the oncology developer at up to $5.8 billion, the latest example of a drugmaker targetingThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Read more »
Elyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulFrom adult diapers to a mini-fridge, Elyse Myers reveals the products she can't live without since giving birth to her second child.
Read more »
Lucrative Bristol Bay red king crab fishery to reopen after 2-year closureThe Alaska Department of Fish and Game announced Friday morning that the lucrative crab fishery will open Oct. 15.
Read more »
Something went wrong. Please disable your blocker on Collider.Michael Myers and Pinhead could have teamed up to raise hell together!
Read more »
Connecticut woman Suzanne Laprise charged with starting shootout at Bristol police stationPolice in Connecticut said they arrested a woman Thursday who entered the Bristol police station and began opening fire on officers.
Read more »